Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways.
第一作者:
Huaqiang,Tao
第一单位:
Department of Orthopedics, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou, Jiangsu 215006, China.
作者:
主题词
动物(Animals);消炎药(Anti-Inflammatory Agents);组织蛋白酶K(Cathepsin K);细胞存活(Cell Survival);香豆素类(Coumarins);细胞因子类(Cytokines);女(雌)性(Female);人类(Humans);基质金属蛋白酶9(Matrix Metalloproteinase 9);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);NF-κB(NF-kappa B);NFATC转录因子类(NFATC Transcription Factors);破骨细胞(Osteoclasts);骨生成(Osteogenesis);骨质疏松, 绝经后(Osteoporosis, Postmenopausal);RANK配体(RANK Ligand);重组蛋白质类(Recombinant Proteins);信号传导(Signal Transduction)
DOI
10.1016/j.phrs.2021.105967
PMID
34740817
发布时间
2022-03-11
- 浏览0
Pharmacological research
105967页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文